Gritstone Oncology Inc (NASDAQ:GRTS)

5.46
Delayed Data
As of Mar 27
 -0.64 / -10.49%
Today’s Change
5.44
Today|||52-Week Range
15.94
-39.13%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Gritstone Oncology Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 16.00. The median estimate represents a +266.30% increase from the last price of 5.46.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Gritstone Oncology Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.73
Sales
$1.3M
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.19%
 
 
 
 
 
 
Growthannually 0.27%
 
 
 
 

Sales

Growthquarterly 41.87%
 
 
 
 
 
 
Growthannually 13.89%
 
 
 
 
Key to the earnings and sales forecast charts.